Well-designed randomized trials provide the highest level of scientific evidence to guide
clinical decision making. In chemoradiotherapy of locally advanced squamous cell …

Head and neck squamous cell carcinoma (HNSCC) is often diagnosed at an advanced
stage and has a dismal prognosis. Nearly 10 years after the approval of cetuximab, anti …

Background Immune checkpoint inhibitors are now standard-of-care treatments for
metastatic cutaneous melanoma. However, for rare sub-groups, such as mucosal …

Simple Summary In patients with inflammatory bowel disease, chronic inflammation is a risk
factor for the development of digestive and nondigestive cancers. The treatment, as in …

Introduction/Background Paraneoplastic neurological syndromes (PNS) are rare
complications of ovarian cancer. We report three (3) cases of high grade serous ovarian …

Serous carcinoma of the uterine cervix (SCUC) is now believed to be a morphological
variant of an HPV-associated endocervical adenocarcinoma or a metastasis from a serous …

Results With the combination of pazopanib and denosumab, there was regression of the
subcutaneous disease and stability of lung and bone metastasis for over a year. The …

Aim: Randomized studies have demonstrated that EVE has antitumour activity in advanced
G1-G2 NETs. However, data in the “real-world” setting outside regulatory trials are limited …

Anaplastic thyroid cancer (ATC) is among the most aggressive cancers with a median
overall survival of 4 months and a disease-specific mortality of close to 100%. As soon as …